Best Doctor's in Gurugram

Dr. Mohit Saxena

Best Medical Oncologist

MBBS, MD (General medicine), DM (Medical Oncology)

Dr. Mohit Saxena


Dr. Mohit Saxena is a Specialist in Medical Oncology, Hematology, Oncology, And Cancer With Clinical experience of 7+ years in the field of Medical Oncology and Hematology after passing DM examination (10+ years) Total of 17+ Year Of experience. Dr. Mohit Saxena received her medical degree from the Gujarat Cancer and Research Institute, B. J. Medical College, Ahmedabad In 2016. Dr. Mohit Saxena has expertise in Immunotherapy, Chemotherapy, Targeted therapy, and precision Medicine Hormone therapy. Dr. Mohit Saxena after completing his MBBS and MD – General Medicine from Sawai Man Singh Medical College and hospital, Jaipur, Rajasthan, after that he has been extensively trained in the management of cancer patients at the Prestigious “Gujarat Cancer and Research Institute (GCRI), Ahmedabad” where he did his DM (Medical Oncology) and worked as a senior resident (Medical Oncology) before moving to Delhi-NCR.
He worked as a consultant, in Medical Oncology at Artemis hospital, Gurugram, Haryana for two and half years. He has vast experience in managing solid tumors and hematological malignancies. He has also worked at VPS Rockland Hospital, Qutub and Manesar; Paras Hospital, Gurugram, and C.K. Birla Hospital, Gurugram, and expanded his experience. His last organization was Fortis Flt. Lt. Rajan Dhall Hospital, Vasant Kunj, New Delhi where he worked as an empaneled consultant. He is the best Medical Oncologist in Gurugram. He is currently working in D Mettle Clinique, Super Specialty Polyclinic OPD Care In Gurugram Haryana 122018


  1. MBBS – Sawai Man Singh Medical College (Jaipur) – 2006
  2. MD – General Medicine – Sawai Man Singh Medical College (Jaipur) – 2010
  3. DM – Medical Oncology – Gujarat Cancer Research Institute (Ahmedabad) – 2016


Immunotherapy, Chemotherapy, Targeted therapy and precision Medicine Hormone therapy


Hindi, English 


  • Senior Resident (Medical Oncology) at Gujarat Cancer & Research Institute, Ahmedabad Mar 2016 – Sept 2016
  • Associate Consultant (Medical Oncology) at VPS Rockland Hospital, Qutub & Manesar April 2017 – July 2018
  • Consultant (Medical Oncology) at Artemis Hospital, Gurgaon Nov 2016 – June 2019
  • Consultant (Medical Oncology) at C. K. Birla Hospital, Gurgaon June 2019 – August 2020
  • Consultant (Medical Oncology) at Paras Hospital, Gurgaon July 2019 – Dec 2019
  • Empaneled Consultant (Medical Oncology) at Fortis Hospital, Vasant Kunj, New Delhi Jan 2020 – August 2020


  1. Acute lymphocytic leukemia Treatment
  2. Acute myelogenous leukemia Treatment
  3. Adnexal tumors Treatment
  4. Adrenal cancer Treatment
  5. Ampullary cancer Treatment
  6. Anal cancer Treatment
  7. Basal cell carcinoma Treatment
  8. Bladder cancer Treatment
  9. Bone cancer Treatment
  10. Brain metastases Treatment
  11. Brain tumor Treatment
  12. Breast cancer Treatment
  13. Cancer Treatment
  14. Carcinoid syndrome Treatment
  15. Carcinoid tumors Treatment
  16. Carcinoma of unknown primary Treatment
  17. Cervical cancer Treatment
  18. Cholangiocarcinoma (bile duct cancer) Treatment
  19. Chondrosarcoma Treatment
  20. Chordoma Treatment
  21. Chronic lymphocytic leukemia Treatment
  22. Chronic myelogenous leukemia Treatment
  23. Colon cancer Treatment
  24. Cushing syndrome Treatment
  25. Cutaneous T-cell lymphoma Treatment
  26. Desmoid tumors Treatment
  27. Desmoplastic small round cell tumors Treatment
  28. Ductal carcinoma in situ (DCIS) Treatment
  29. Endometrial cancer Treatment
  30. Esophageal cancer Treatment
  31. Esthesioneuroblastoma Treatment
  32. Ewing sarcoma Treatment
  33. Floor of the mouth cancer Treatment
  34. Gallbladder cancer Treatment
  35. Gastrointestinal stromal tumor (GIST) Treatment
  36. Germ cell tumors Treatment
  37. Glioma Treatment
  38. Head and neck cancers Treatment
  39. Hodgkin’s lymphoma  (Hodgkin’s disease) Treatment
  40. Hurthle cell cancer Treatment
  41. Inflammatory breast cancer Treatment
  42. Invasive lobular carcinoma Treatment
  43. Kidney cancer Treatment
  44. Leukemia Treatment
  45. Lip cancer Treatment
  46. Liposarcoma Treatment
  47. Liver cancer Treatment
  48. Lung cancer Treatment
  49. Lymphoma Treatment
  50. Lynch syndrome Treatment
  51. Male breast cancer Treatment
  52. Malignant peripheral nerve sheath tumors Treatment
  53. Melanoma Treatment
  54. Meningioma Treatment
  55. Merkel cell carcinoma Treatment
  56. Mesothelioma Treatment
  57. Mouth cancer Treatment
  58. Multiple endocrine neoplasia, type 1 (MEN 1) Treatment
  59. Multiple endocrine neoplasia, type 2 (MEN 2) Treatment
  60. Multiple myeloma Treatment
  61. Myelofibrosis Treatment
  62. Nasal and paranasal tumors Treatment
  63. Nasopharyngeal carcinoma Treatment
  64. Neuroblastoma Treatment
  65. Neuroendocrine tumors Treatment
  66. Neurofibromatosis Treatment
  67. Non-Hodgkin’s lymphoma Treatment
  68. Nonmelanoma skin cancer Treatment
  69. Osteosarcoma Treatment
  70. Ovarian cancer Treatment
  71. Pancreatic cancer Treatment
  72. Pancreatic neuroendocrine tumors Treatment
  73. Paraneoplastic syndromes of the nervous system Treatment
  74. Peripheral nerve tumors Treatment
  75. Pheochromocytoma Treatment
  76. Pituitary tumors Treatment
  77. Prostate cancer Treatment
  78. Rectal cancer Treatment
  79. Rhabdomyosarcoma Treatment
  80. Salivary gland tumors Treatment
  81. Sarcoma Treatment
  82. Skin cancer Treatment
  83. Small bowel cancer Treatment
  84. Soft palate cancer Treatment
  85. Soft tissue sarcoma Treatment
  86. Solitary fibrous tumor Treatment
  87. Spinal cord tumor Treatment
  88. Squamous cell carcinoma of the skin Treatment
  89. Stage 4 prostate cancer Treatment
  90. Stomach cancer Treatment
  91. Suspicious breast lumps Treatment
  92. Testicular cancer Treatment
  93. Throat cancer Treatment
  94. Thyroid cancer Treatment
  95. Tongue cancer Treatment
  96. Tonsil cancer Treatment
  97. Undifferentiated pleomorphic sarcoma Treatment
  98. Ureteral cancer Treatment
  99. Vaginal cancer Treatment
  100. Vertebral tumor Treatment
  101. Vulvar cancer Treatment
  102. Waldenstrom macroglobulinemia Treatment

best medical oncologist

Patient Consulted
0 +

best medical oncologist

Year of Experiences
0 +

Patient Testimonials

Raakesh Ahuja

Dr. Mohit Saxena is undoubtedly the best Medical Oncologist in Gurugram. His expertise and compassionate care are unparalleled.

Tarun Arora

I'm grateful to have found Dr. Mohit Saxena, the best Medical Oncologist in Gurugram. His guidance and support during my cancer journey were invaluable.

Naman Chopra

If you're seeking top-notch oncology care in Gurugram, look no further than Dr. Mohit Saxena. His reputation as the best is well-deserved.

Abdul Majid

Dr. Mohit Saxena commitment to his patients' well-being is evident. He truly is the best Medical Oncologist in Gurugram.

Palak Banerjee

I couldn't have asked for a better medical professional than Dr. Mohit Saxena. He is, without a doubt, the best Medical Oncologist in Gurugram

Parkash Chandra

Dr. Mohit Saxena's knowledge and dedication are unmatched. He is the epitome of the best Medical Oncologist in Gurugram.

Danish Ahmed

Choosing Dr. Mohit Saxena as my oncologist was the best decision I made. He truly is the best Medical Oncologist in Gurugram.

Kanika Deshmukh

Dr. Mohit Saxena expertise and caring approach set him apart as the best Medical Oncologist in Gurugram.

Balaraj Gupta

I've recommended Dr. Dheeraj Kapoor to friends and family without hesitation. His knack for simplifying complex endocrine issues is truly impressive.

Abhey Joshi

I'm grateful for Dr. Mohit Saxena guidance throughout my cancer treatment. He's the best Medical Oncologist in Gurugram for a reason.

Kadeer Badie

Dr. Mohit Saxena's skill and compassion make him the go-to choice for anyone seeking the best Medical Oncologist in Gurugram.

Ganesh Kashyap

As a patient, I can confidently say that Dr. Mohit Saxena is the best Medical Oncologist in Gurugram. His care is exceptional.

Madhav Khanna

I consider myself lucky to have had Dr. Mohit Saxena as my oncologist. He is, without a doubt, the best Medical Oncologist in Gurugram.

Darpan Kohli

Dr. Mohit Saxena's expertise and compassionate nature make him the best Medical Oncologist in Gurugram.

Vaibhav Kumar

I can't thank Dr. Mohit Saxena enough for his exceptional care. He truly is the best Medical Oncologist in Gurugram.

Medical Oncology

Medical Oncology is the use of drugs to destroy rapidly growing cancer cells. Some kinds of chemotherapy may slow the growth of cancer cells, and keep them from spreading to other parts of the body. It may be used with radiation to help shrink the tumor before surgery. It may also be used after surgery or radiation to destroy remnant cancer cells. The medical oncology team has expertise in the use of systemic treatment including chemotherapy, endocrine therapy, as well as the latest biological and targeted treatments for solid tumors.

best medical oncologist

Medical oncologists frequently handle a spectrum of oncological conditions such as

  • Acute Lymphocytic Leukemia (ALL) is a form of cancer impacting the blood and bone marrow. It manifests through the swift generation of immature white blood cells, known as lymphoblasts. This excessive growth of abnormal cells disrupts the balance, resulting in a reduction in the production of vital, healthy blood cells.
  • Acute Myeloid Leukemia (AML), alternatively termed acute myelogenous leukemia, is a form of cancer impacting the blood and bone marrow. This condition is distinguished by the swift proliferation of aberrant myeloid cells, immature white blood cells that typically undergo maturation into various types of fully developed blood cells.
  • Adnexal tumors encompass growths or masses originating from the adnexal structures within the body. Adnexa typically encompasses appendages or supplementary structures, particularly in the medical context where it commonly denotes structures affiliated with the skin or other organs. Adnexal tumors manifest as growths in diverse locations, including but not limited to the skin, ovaries, or neighboring structures.
  • Carcinoid tumors represent a category of gradually advancing neuroendocrine tumors that may manifest in diverse anatomical locations, with a predilection for the gastrointestinal tract (predominantly the appendix), lungs, and rectum. Originating from neuroendocrine cells, these tumors derive from cells tasked with hormone production, thereby overseeing a range of physiological functions.
  • Ampullary cancer is a unique and uncommon form of cancer originating in the ampulla of Vater. This specialized site marks the convergence point of the common bile duct and pancreatic duct, releasing their contents into the initial segment of the small intestine known as the duodenum. Positioned within the first part of the small intestine, ampullary cancer is a rare and distinctive malignancy.
  • Brain metastases denote the migration of cancerous cells originating from a primary tumor in another part of the body to the brain. This phenomenon, termed metastasis, transpires as cancer cells detach from the initial tumor, traversing the bloodstream or lymphatic system to establish fresh tumors in various regions of the body, notably the brain.
  • Basal cell carcinoma (BCC) stands as the prevailing form of skin cancer, frequently originating in regions exposed to sunlight, including the face, ears, neck, scalp, chest, back, and shoulders. Characterized by a gradual growth rate, BCC seldom metastasizes to distant body areas; however, if left untreated, it can inflict localized harm.
  • Carcinoma of Unknown Primary (CUP) is an oncological term referring to a specific type of cancer characterized by the absence of information about the primary site or origin of the tumor at the point of diagnosis. Essentially, cancer cells are detected in a particular area of the body, but the precise location where the cancer initiated remains unidentified.
  • Chronic Myelogenous Leukemia (CML) stands as a malignancy impacting the blood and bone marrow, marked by the unrestrained proliferation of white blood cells. This variant of leukemia is closely linked to a distinct genetic anomaly recognized as the Philadelphia chromosome. This abnormality arises from a translocation event involving genetic material exchange between chromosomes 9 and 22.
  • Cushing Syndrome arises from prolonged exposure of the body's tissues to elevated levels of cortisol, a hormone synthesized by the adrenal glands. The following highlights key aspects of Cushing's syndrome.
  • Chondrosarcoma is a rare cancer variant that initiates in the cells of cartilage, the resilient and elastic tissue responsible for joint cushioning. This particular form of cancer is less common when compared to other sarcoma types.
  • Carcinoid syndrome is an uncommon ailment that may manifest in individuals diagnosed with carcinoid tumors. These tumors, belonging to the neuroendocrine tumor category, commonly emerge in either the gastrointestinal tract or the lungs. They have the capacity to generate and discharge various chemicals, including serotonin, directly into the bloodstream.
  • Discover a unique form of non-Hodgkin lymphoma known as Cutaneous T-cell Lymphoma (CTCL), which predominantly impacts the skin. This rare cancer variant stems from the T-cells, vital components of the immune system. Dive into the intricacies of this condition and gain insights into the role of T-cells, the powerhouse behind our body's immune defense.
  • Desmoplastic Small Round Cell Tumor (DSRCT) stands out as a rare and highly aggressive form of cancer predominantly impacting adolescents and young adults. Initially identified as a unique entity in the late 1980s, DSRCT typically manifests within the abdominal cavity, notably in the peritoneum—the lining of the abdominal cavity. Nevertheless, it is noteworthy that DSRCT may also emerge in various other regions of the body.
  • Endometrial cancer is a specific form of cancer that initiates within the uterine lining, scientifically termed the endometrium. This vital inner layer of the uterus undergoes dynamic transformations throughout the menstrual cycle, serving as the receptive environment for the attachment and growth of a fertilized egg during the course of pregnancy.
  • Ewing sarcoma stands as a rare form of cancer, predominantly impacting both bones and soft tissues. While it commonly manifests in the long bones like the femur, tibia, and humerus, its occurrence is not exclusive to these structures and can extend to other bones and soft tissues. This particular malignancy tends to be more prevalent in the pediatric and young adult demographic, typically surfacing between the ages of 10 and 20.
  • Gallbladder cancer is an uncommon variant of cancer originating in the gallbladder, a small organ situated beneath the liver. Responsible for storing bile, a digestive fluid crafted by the liver, the gallbladder plays a crucial role in the digestive process. Despite its rarity, gallbladder cancer poses a challenge due to its aggressive nature and the challenges associated with early detection.
  • Floor of the mouth cancer pertains to a form of cancer that initiates within the oral cavity, precisely in the region beneath the tongue recognized as the floor of the mouth. This category of cancer constitutes a subset of oral cavity cancer, encompassing malignancies affecting the lips, tongue, gums, cheeks, and the floor of the mouth.
  • Germ cell tumors are a type of cancer that originates in the cells that give rise to sperm or eggs. These cells, known as germ cells, are responsible for the development of reproductive cells (sperm and eggs) in the testicles or ovaries. Germ cell tumors can occur in both males and females, although the characteristics and treatment may vary between the two.
  • Chronic lymphocytic leukemia (CLL) is a form of cancer originating in the immune system's lymphocytes, particularly affecting B cells. These specialized lymphocytes play a pivotal role in antibody production, contributing to the body's defense against infections.
  • Hurthle cell cancer, alternatively referred to as Hurthle cell carcinoma or oxyphilic cell carcinoma, is a distinct form of thyroid cancer originating from the follicular cells within the thyroid gland. This nomenclature is derived from Karl Hurthle, a notable German pathologist credited with the initial characterization of these cells.
  • Lip cancer denotes the emergence of malignant cells on either the upper or lower lip. The predominant form of lip cancer is squamous cell carcinoma, originating from the slender, flat cells that compose the lip surface.
  • Invasive Lobular Carcinoma (ILC) represents a form of breast cancer initiating within the milk-producing glands, or lobules, of the breast, subsequently infiltrating neighboring breast tissues. Constituting the second most prevalent category of invasive breast cancer, it comprises approximately 10-15% of all breast cancer cases.
  • Hepatic cancer, commonly referred to as liver cancer, originates in the liver cells. Situated in the upper right abdomen, the liver is a crucial organ pivotal to diverse bodily functions such as detoxification, metabolism, and protein synthesis. Understanding the key aspects of liver cancer is essential for informed health awareness.
  • Lung cancer emerges from the cells in the lungs and stands as a predominant contributor to global cancer-related fatalities. This malignancy is broadly categorized into two primary types: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Understanding these distinctions is crucial for grasping the complexities of lung cancer and its impact on health.
  • Melanoma, a form of skin cancer, arises from melanocytes, the skin's pigment-producing cells. These specialized cells generate melanin, the pigment responsible for skin, hair, and eye coloration. While melanoma is less prevalent compared to other skin cancers, its heightened aggressiveness underscores the importance of early detection and treatment to prevent its potential spread to other bodily regions.
  • Oral cancer, commonly referred to as mouth cancer, encompasses the growth of malignant cells within various oral components, such as the lips, tongue, gums, floor of the mouth, and the palate (roof of the mouth). This form of cancer falls under the category of head and neck cancers.
  • Lymphoma emerges as a form of cancer originating within the cells of the lymphatic system, an integral component of the body's immune defenses. This intricate network encompasses lymph nodes (compact, bean-shaped glands), the spleen, thymus, and bone marrow. The two primary classifications of lymphoma are Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL).
  • Malignant Peripheral Nerve Sheath Tumors (MPNSTs) represent a form of cancer originating from the cells enveloping peripheral nerves, those situated outside the brain and spinal cord. While these tumors have the potential to manifest in various bodily locations, they typically occur more frequently in the extremities, trunk, and head.
  • A meningioma is a tumor that originates from the meninges, the protective layers of tissue enveloping the brain and spinal cord. Generally characterized by slow growth, these tumors are commonly benign (non-cancerous), yet their impact on an individual's health can vary based on their size and location.
  • Multiple myeloma is a form of cancer originating in plasma cells, specialized white blood cells tasked with antibody production. In cases of malignancy, these cells undergo unregulated multiplication, generating abnormal antibodies and resulting in diverse complications.
  • Neuroblastoma, a childhood cancer, predominantly impacts the adrenal glands atop the kidneys. Additionally, it may manifest in nerve tissue along the spine, chest, abdomen, or pelvis.
  • Pancreatic Neuroendocrine Tumors (PNETs) are a distinct tumor variant originating in the pancreas, deriving from hormone-producing cells. In contrast to prevalent pancreatic tumors like pancreatic adenocarcinoma, known for its aggressive nature, PNETs exhibit a relatively slower growth rate.
  • Myelofibrosis represents a rare form of bone marrow disorder categorized within the realm of myeloproliferative neoplasms. In this pathological state, the bone marrow, tasked with the production of blood cells, experiences aberrant transformations. The hallmark of myelofibrosis lies in the heightened generation of fibrous tissue within the bone marrow, resulting in the displacement of conventional blood-forming cells.
  • Discover the intricacies of Multiple Endocrine Neoplasia, Type 2 (MEN 2), an uncommon genetic condition impacting the endocrine system. This disorder manifests through the formation of tumors in specific endocrine glands, pivotal for generating hormones that govern diverse bodily functions. The root cause of MEN 2 lies in mutations affecting the RET proto-oncogene. Uncover the details of this rare genetic disorder and its implications for the endocrine system.
  • Prostate cancer manifests as a malignancy originating in the prostate—a diminutive, walnut-shaped gland responsible for seminal fluid production in men. Predominantly prevalent among older males, it ranks as one of the most frequently diagnosed cancer types in the male population.
  • Neurofibromatosis (NF) is a hereditary condition impacting the nervous system, leading to the development of tumors along nerves. This disorder manifests in three distinct types: NF1, NF2, and Schwannomatosis.
  • Pheochromocytoma is an uncommon neoplasm typically originating in the adrenal glands situated atop each kidney. These tumors emanate from chromaffin cells responsible for synthesizing and releasing hormones like adrenaline and noradrenaline (epinephrine and norepinephrine). The overproduction of these hormones can result in a diverse range of symptoms and potential complications.
  • Rhabdomyosarcoma is a cancer variant originating from cells typically responsible for the formation of skeletal muscles—muscles crucial for governing bodily movements and connected to the bones. Although prevalent in children and adolescents, this malignancy is not limited by age, potentially affecting individuals at any stage of life.
  • Skin cancer originates from the abnormal growth of skin cells, making it the most prevalent form of cancer. This condition develops when skin cells undergo damage, often due to exposure to the sun's ultraviolet (UV) rays or other UV radiation sources, such as tanning beds.
  • Small intestine cancer, alternatively referred to as small bowel cancer, is an uncommon form of cancer originating in the small intestine. Positioned as a vital component linking the stomach to the large intestine, the small intestine significantly contributes to the digestion and absorption of nutrients derived from our dietary intake.
  • Peripheral nerve tumors are growths that form within or on the peripheral nerves, situated outside the brain and spinal cord. These tumors can originate from various cell types within the nerves and may be categorized as either benign (non-cancerous) or malignant (cancerous). Responsible for relaying signals between the central nervous system (the brain and spinal cord) and the entire body, peripheral nerves play a crucial role in bodily functions. Explore more about peripheral nerve tumors and their impact on nerve health.
  • Soft palate cancer manifests within the fleshy and pliable region of the mouth's roof, situated at the rear of the throat. This particular form of cancer affects the soft palate, a vital component influencing speech and swallowing functions.
  • Gastric cancer, or stomach cancer, initiates within the stomach lining. While not as prevalent, this form of cancer is a significant and potentially life-threatening health concern.
  • Discover the intricacies of spinal cord tumors, where abnormal cell growth occurs within or near the spinal cord. These tumors may fall into two categories: benign, representing non-cancerous formations, or malignant, indicating cancerous growth. Originating either within the spinal cord itself (intrinsic) or externally (extrinsic), understanding these distinctions is crucial for comprehensive awareness.
  • Ureteral cancer, alternatively referred to as ureter cancer, represents a seldom-encountered malignancy originating in the inner lining of the ureter—the conduit linking the kidneys to the bladder. These slender tubes play a crucial role in the transportation of urine from the kidneys to the bladder.
  • Undifferentiated Pleomorphic Sarcoma (UPS), alternatively recognized as Malignant Fibrous Histiocytoma (MFH), represents a variant of soft tissue sarcoma. Within the spectrum of soft tissue sarcomas, a heterogeneous category of cancers originating in the body's connective tissues—including muscles, tendons, adipose tissue, blood vessels, nerves, and other supporting structures—UPS stands out as a distinctive subtype.
  • In the advanced phase of prostate cancer, specifically in Stage 4, the malignancy has extended beyond the confines of the prostate and infiltrated various regions within the body. Progression may involve adjacent tissues, lymph nodes, or remote organs. The primary objectives of addressing stage 4 prostate cancer revolve around symptom management, impeding disease advancement, and enhancing overall quality of life. Treatment modalities at this stage are strategically designed to achieve these goals.
  • Tonsil cancer, a condition characterized by the growth of cancer cells in the tonsils situated at the rear of the throat, poses a significant health concern. The predominant form of tonsil cancer is squamous cell carcinoma.
  • Vaginal cancer is an uncommon form of cancer that originates in the vaginal cells, the muscular tube linking the uterus to the external genitals. Similar to numerous cancers, the precise cause of vaginal cancer remains elusive; however, specific factors may elevate the likelihood of encountering this condition.
  • A vertebral tumor is characterized by the atypical proliferation of cells within the vertebrae, the diminutive bones constituting the spinal column. These tumors may manifest as primary, originating directly within the bone, or secondary, emanating from another bodily region and extending to the vertebrae. Understanding the distinct types of vertebral tumors is crucial for effective diagnosis and targeted treatment.
  • Inflammatory Breast Cancer (IBC) stands out as an uncommon and highly aggressive variant of breast cancer, constituting a minimal proportion of overall breast cancer instances. Diverging from typical tumor-forming breast cancers, IBC deviates by frequently lacking a discernible lump or mass. Instead, it typically manifests through conspicuous signs such as heightened redness, swelling, and warmth in the breast area. The skin texture may display a pitted or dimpled appearance akin to that of an orange peel. The progression of these symptoms is often swift, leading to a notable increase in size, firmness, and tenderness of the affected breast.
  • Adrenal cancer, alternatively referred to as adrenal gland cancer, represents a seldom-encountered form of cancer originating within the adrenal glands. Situated atop each kidney, these glands assume a pivotal role in the synthesis of hormones that govern diverse physiological processes, such as metabolism, blood pressure regulation, and stress response.
  • Bone cancer is an infrequent form of cancer originating from the cells constituting the skeletal structure. While it can manifest in any bone throughout the body, it predominantly impacts the elongated bones, specifically those found in the limbs. Various types of bone cancer exist, with osteosarcoma and Ewing sarcoma standing out as the most prevalent among them.
  • Breast cancer emerges when abnormal cell growth initiates in the breast tissues. This form of cancer is not gender-exclusive and can affect both men and women; however, it is notably more prevalent in the female population. Understanding the basics of breast cancer is crucial for promoting awareness and early detection.
  • Chordoma represents an uncommon form of cancer manifesting in the skeletal structures of the spine and skull. It emerges from residual notochord tissues, a pliable rod-like structure integral to early embryonic development and spine formation. Predominantly, chordomas impact the sacrum (base of the spine) or the skull, with a particular affinity for the clivus, the sloping region at the skull's base.
  • Cancer manifests as a cluster of illnesses distinguished by the unrestricted proliferation and dissemination of aberrant cells. Various forms of cancer exist, capable of emerging in nearly any bodily tissue or organ. The essential hallmark of cancer lies in the formation of an abnormal tissue mass, referred to as a tumor, that infiltrates and disrupts neighboring, healthy tissues.
  • Bladder cancer manifests as a malignancy originating in the bladder's cells, a vital hollow pelvic organ tasked with urine storage. The predominant form of bladder cancer is transitional cell carcinoma, commencing in the cells that coat the interior of the bladder.
  • Cervical cancer manifests in the cells of the cervix, the lower segment of the uterus linked to the vagina. The primary instigator of most cervical cancer cases is the human papillomavirus (HPV), a sexually transmitted infection.
  • Colorectal cancer, commonly referred to as colon cancer, is a form of cancer that initiates in the colon or rectum. These components are integral parts of the large intestine, the concluding segment of the digestive system. The onset of colon cancer typically commences with the development of a polyp, a growth that may either be non-cancerous (benign) or cancerous (malignant).
  • Desmoid tumors, alternatively termed aggressive fibromatosis or desmoid-type fibromatosis, represent uncommon yet locally invasive neoplasms originating from connective tissue. While these tumors may manifest in diverse anatomical regions, the abdominal wall is the predominant site, although they can also manifest in the extremities, chest wall, and other bodily locations.
  • Cholangiocarcinoma, often referred to as bile duct cancer, represents a rare yet highly aggressive form of cancer emerging within the bile ducts. These slender tubes play a pivotal role in transporting bile—a digestive fluid synthesized by the liver—to the small intestine. Cholangiocarcinoma has the potential to manifest at various locations along the intricate network of bile ducts, spanning from the liver to the small intestine.
  • Ductal Carcinoma In Situ (DCIS) represents a non-invasive manifestation of breast cancer wherein irregular cells are detected within the confines of a breast duct, without extending beyond its boundaries. The term "in situ" denotes that the cancerous cells remain localized within the duct, without encroaching upon neighboring tissues.
  • Esthesioneuroblastoma, alternatively referred to as olfactory neuroblastoma, is a scarce form of cancer emerging from the olfactory nerve, responsible for our sense of smell. This unique cancer primarily impacts the upper nasal cavity, potentially spreading to adjacent areas like the sinuses and the base of the skull. Learn more about the characteristics and implications of esthesioneuroblastoma in this insightful guide.
  • Endometrial cancer is a specific form of cancer that initiates within the uterine lining, scientifically termed the endometrium. This vital inner layer of the uterus undergoes dynamic transformations throughout the menstrual cycle, serving as the receptive environment for the attachment and growth of a fertilized egg during the course of pregnancy.
  • A brain tumor refers to an atypical proliferation of cells in the brain or central spinal canal. These growths may be categorized as either malignant (cancerous) or benign (noncancerous). Primary tumors initiate within the brain, while secondary or metastatic tumors develop when abnormal cells migrate to the brain from other areas of the body.
  • Head and neck cancers encompass a cluster of malignancies that arise within the tissues and organs situated in the head and neck vicinity. This category encompasses cancers affecting the mouth, throat, nose, sinuses, salivary glands, and various other regions. To shed light on this subject, let's delve into some essential aspects of head and neck cancers.
  • A glioma is a tumor originating from glial cells, essential support cells within the central nervous system encompassing the brain and spinal cord. Among adults, gliomas stand out as the predominant form of primary brain tumors.
  • Gastrointestinal Stromal Tumor (GIST) belongs to the category of soft tissue sarcomas, specifically originating in the gastrointestinal (GI) tract. These tumors stem from unique cells known as interstitial cells of Cajal, located in the GI tract's wall. These cells play a crucial role in regulating digestive tract contractions.
  • Hodgkin's lymphoma, alternatively referred to as Hodgkin's disease, is a form of cancer impacting the lymphatic system. This condition is identified by the existence of Reed-Sternberg cells, which are notably large and abnormal cells commonly located within the lymph nodes.
  • Renowned as renal cancer, kidney cancer emerges within the essential organs responsible for filtering blood waste to produce urine. Renal cell carcinoma (RCC) and transitional cell carcinoma (TCC) stand out as the predominant forms of kidney cancer, originating within the kidneys, crucial for waste elimination from the bloodstream.
  • Liposarcoma is a rare form of cancer that develops from fat cells. Classified as a soft tissue sarcoma, it emerges within the body's soft tissues, encompassing muscles, tendons, and adipose tissue. Liposarcomas represent approximately 20% of all soft tissue sarcomas, making them a less common but noteworthy malignancy.
  • Leukemia stands as a form of cancer impacting the blood and bone marrow. Its distinctive feature lies in the atypical generation of white blood cells, pivotal in combating infections. In this condition, the bone marrow overproduces a significant quantity of immature or irregular white blood cells, ultimately displacing the usual complement of healthy blood cells.
  • Lynch syndrome, alternatively referred to as hereditary nonpolyposis colorectal cancer (HNPCC), is a hereditary genetic condition that elevates the susceptibility to a range of cancers, with a notable emphasis on colorectal cancer. This autosomal dominant disorder implies that an individual afflicted with Lynch syndrome bears a 50% likelihood of transmitting the altered gene to their descendants.
  • Merkel Cell Carcinoma (MCC) stands out as an uncommon and highly aggressive form of skin cancer. Its usual emergence transpires on regions of the skin that are frequently exposed to sunlight, including the head, neck, and extremities. Merkel cells, vital for the sense of touch, are the origin points of this malignancy within the skin.
  • Mesothelioma is a form of cancer that predominantly impacts the lung lining (pleura), with occurrences also possible in the abdominal lining (peritoneum), heart lining (pericardium), and testicular lining (tunica vaginalis). The primary culprit behind mesothelioma is exposure to asbestos, a naturally-occurring mineral extensively employed in construction, insulation, and various industries.
  • Nonmelanoma skin cancer refers to a type of skin cancer that arises from the cells in the skin other than melanocytes. Melanocytes are the cells that produce melanin, the pigment responsible for the color of the skin, hair, and eyes. The two main types of nonmelanoma skin cancer are basal cell carcinoma (BCC) and squamous cell carcinoma (SCC).
  • Occasionally, male breast cancer emerges as a rare yet plausible manifestation of cancer affecting the breast tissue in men. Although breast cancer predominantly afflicts women, it is crucial to recognize that men too can experience the onset of this condition.
  • Nasal and paranasal tumors are characterized by the emergence of irregular growths or masses within the nasal cavity or the paranasal sinuses. These sinuses encompass air-filled spaces surrounding the nasal cavity, comprising the frontal, ethmoid, sphenoid, and maxillary sinuses.
  • Anal cancer is an uncommon type of cancer that originates in the tissues of the anus, the terminal opening of the digestive tract. This vital body region serves as the passage for stool elimination from the body.
  • Neuroendocrine tumors (NETs) represent a category of neoplasms originating from neuroendocrine cells distributed throughout the body, tasked with hormone production. These growths have the potential to emerge in diverse organs such as the pancreas, gastrointestinal tract, lungs, and various other anatomical regions.
  • Non-Hodgkin's lymphoma (NHL) is a form of cancer that begins in the lymphatic system, a vital component of the immune system. Distinguishing itself from Hodgkin's lymphoma, non-Hodgkin's lymphoma entails the excessive growth of atypical lymphocytes, a specific type of white blood cell, and can manifest in diverse regions throughout the body. Discover more about this condition and its implications for overall health.
  • Osteosarcoma emerges as a form of bone cancer, predominantly impacting osteoblasts—the cells pivotal in crafting fresh bone tissue. As the prevalent primary malignant bone tumor, it usually manifests in lengthy bones like arms and legs. This condition frequently arises amid the phase of swift bone development in adolescence and early adulthood.
  • Pancreatic cancer emerges from the cells of the pancreas, an organ situated behind the stomach. Renowned for its aggressive characteristics, this cancer is frequently identified in later stages, posing significant challenges for effective treatment.
  • The pituitary gland, commonly known as the "master gland," is a diminutive pea-sized organ situated at the base of the brain. Its pivotal function involves the orchestration of diverse bodily functions through the synthesis and release of hormones, governing pivotal aspects such as growth, metabolism, reproduction, and other vital processes.
  • Salivary gland tumors manifest as abnormal growths within the salivary glands, integral to saliva production. Situated in proximity to the mouth and throat, these glands hold a pivotal role in digestion by generating saliva, a vital component for breaking down food.
  • Rectal cancer emerges from the cells of the rectum, the terminal portion of the large intestine concluding at the anus. Typically categorized as a subtype of colorectal cancer, alongside colon cancer, rectal cancer exhibits numerous parallels with its counterpart. Despite these similarities, the treatment approaches for rectal cancer and colon cancer diverge.
  • Sarcoma represents a distinct category of cancer emerging from the body's connective tissues, encompassing muscles, bones, tendons, cartilage, nerves, fat, and blood vessels. In contrast to the more prevalent carcinomas originating from epithelial cells, sarcomas are relatively rare in occurrence.
  • Soft palate cancer manifests within the fleshy and pliable region of the mouth's roof, situated at the rear of the throat. This particular form of cancer affects the soft palate, a vital component influencing speech and swallowing functions.
  • A solitary fibrous tumor (SFT) is an uncommon soft tissue neoplasm that may manifest in diverse anatomical regions throughout the body. Initially thought to predominantly impact the pleura, the membranous covering of the lungs, SFT has subsequently been identified in alternative locations.
  • Paraneoplastic syndromes related to the nervous system represent a set of uncommon conditions linked to cancer, yet distinct from direct tumor impact or metastasis. These syndromes stem from an immune reaction targeting the tumor, causing harm to healthy tissues, specifically within the nervous system. Manifesting in both the central nervous system  and the peripheral nervous system (encompassing nerves outside these regions), paraneoplastic syndromes present a unique challenge often necessitating specialized care.
  • Squamous cell carcinoma (SCC) is a prevalent form of skin cancer originating from flat cells known as squamous cells in the outer epidermal layer. It frequently manifests in sun-exposed regions like the face, ears, neck, lips, and the dorsal surfaces of the hands.
  • Ovarian cancer originates in the ovaries, integral components of the female reproductive system. While it is uncommon, this form of cancer is notably severe and frequently poses a significant threat to health.
  • Testicular cancer arises when abnormal cells in the testicles undergo uncontrolled growth. Positioned within the male reproductive system, the testicles, or testes, play a pivotal role in sperm and male hormone production. Although relatively uncommon, testicular cancer stands out as the predominant cancer affecting young men between the ages of 15 and 35.
  • Discovering a lump in the breast can be a source of apprehension. It's crucial to emphasize that not all breast lumps indicate cancer; diverse factors, including cysts or fibroadenomas, can contribute to their formation. Nevertheless, any novel or dubious lump in the breast warrants assessment by a qualified healthcare professional.
  • Tongue cancer refers to the development of malignant cells on the tongue, which is a vital organ responsible for functions like speech, taste, and swallowing. It is a type of oral cancer and can occur on the front (anterior) or back (posterior) part of the tongue.
  • Throat cancer denotes the emergence of cancerous growths in the throat region, encompassing the voice box (larynx), vocal cords, and other segments like the oropharynx and hypopharynx.
  • Waldenström Macroglobulinemia (WM) is a distinctive and slowly progressing form of lymphoma, belonging to the non-Hodgkin lymphomas group—a category of cancers affecting the lymphatic system. This rare ailment is marked by the excessive generation of a particular antibody known as IgM (immunoglobulin M) by malignant lymphocytes, a subtype of white blood cells.

Our Contact

Get In Touch

Discover the unbeatable potential of our D Mettle clinic! Allow us to address all your queries and concerns, leaving no room for doubts. Our team is delighted to provide you with comprehensive answers to any questions you may have. Alternatively, take the first step towards a transformative experience by booking a call with us. Let our expert staff guide you through the possibilities and advantages awaiting you at our clinic. Don’t miss this chance to unlock a world of wellness and possibilities. Embrace the future of better health today!


+91 844 855 4489



+91-124 4976 724


+91-844 855 4489